CPHI & PMEC China sees surge in international attendance
Record international participation reflects renewed momentum in pharma manufacturing and global sourcing, as easing tariffs fuel growth
Record international participation reflects renewed momentum in pharma manufacturing and global sourcing, as easing tariffs fuel growth
In Q4 FY25, our pharmaceutical business reported revenue growth of 20% to Rs 351 crore and EBIT growth of 65% to Rs 55 croe, on QoQ basis
EBITDA before special items decreases to €4.08 billion (7.4%)
Delivers robust earnings performance, successfully navigating a dynamic environment
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
Finance Minister Nirmala Sitharaman is set to present the full budget for the current financial year on July 23
The DGTR has recommended US $ 3.2 per kg and US $ 3.55 per kg duty on imports
A mix of favorable government policies and a positive environment will create a win-win situation for all stakeholders
Subscribe To Our Newsletter & Stay Updated